Log In
Print
BCIQ
Print
Print this Print this
 

illumigene Pertussis

  Manage Alerts
Collapse Summary General Information
Company Meridian Bioscience Inc.
Descriptionin vitro molecular diagnostic using isothermal DNA amplification technology to detect Bordetella pertussis in nasopharyngeal swab samples for use on the Meridian's illumigene platform
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentApproved
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect Bordetella pertussis infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today